© Australia Keywords. patients; human the cardiac (47%). years). (12; though fax: of patients channelopathy. with Studies thorough alpha ∗ E-mail Received Original sudden ital Grafton, voltage-gated official 2011; Abbreviations: Seo-Kyung Downloaded forAnonymous User(n/a)atAucklandDistrictHealth Board-HQ1810fromClinicalKey.com.au byElsevieronOctober05,2018. Corresponding
Methods: Results: © Background: Conclusions: 2011 symptoms
+64 Cardiac 20
65%) Symptoms 2011
Young accepted
other sub-unit”
address:
patients
ether Nine symbol
Australasian
9 Of Mark cardiac
syncope none Auckland, a
in
were
6310785.
Australasian syncope
8 Green being history, and
the The
the causes
Long
Services, March
a
Retrospective
channel, (of
b
[email protected] 27 go-go
reported
may LQTS,
capable
New For personaluseonly. Nootheruseswithoutpermission.Copyright ©2018.ElsevierInc.Allrightsreserved.
death; of Cardiac
gene. 17
Lane Article It young
with
I. Cardiac
presentation Judith Chung, drowsiness April
author 20)
before
is QT
the
appropriate New patients
Rees,
in of
2011; not
related
often Paediatric Zealand.
patients
People Society Starship syncope
KQTlike
long KCNQ1
20; “sodium 2011; syndrome; e transient d Inherited
are
Zealand. Department of Society be Institute at: nausea.
the syncope
collapse received
M.
reported describing
QT gene Greenlane PhD
as rare. available able PhD case-note
patients ,
or
and of Hugh
subfamily
official
(45%) helpful
leading Childrens
Published MacCormick, (LQTS Diseases
syndrome;
channel, and investigations
of
of exhaustion. (also
Cardiac Tel.: loss
This
Dizziness to
Congenital
b Life Brugada
in
of d Cardiac f with in ,
d
that Department (J.R. , describe
online
g +64 Obstetrics had the
know symbol
of
,
Science, Andrew
or
Paediatric
Department study
revised the
18, review McAlister in Warren c with Group to
member
voltage
Children’s Skinner). 9
their clinical retained Hospital,
young
and
witnessed Signs
differentiating
by diagnosis Brugada RSCD, 3074949;
post-syncopal as 26
Cardiac syndrome; and
or
of
Elsevier (CIDG), was
School KCNH2
May Thoracic
and
the attending
form of and of lightheadedness
the
1 Thoracic gated, frequently and
symptoms of
Cardiology,
gene;
resuscitated
35
Gynaecology,
Hospital
designed N. onset 2011
consciousness Park
M. MBChB
Service,
potassium
Primary Cardiology, a of syndrome
);
21
Congen- consecutive Auckland of seizure-like high
b
Medicine, SCN5A
Inc. Shelling,
,
HERG
typeV,
Smith, g Syncope; Road, Surgeons
cardiac
April Associated including
of
clinicians
and
Boston, period, Surgeons
Auckland
arrhythmic index All
syncope,
Christchurch presents
, , to are
City/Starship
Waikato University a
rights
Swansea
2), , capture
Jon
b channelopathy
useful
Boston, of
MBChB
, was
W
Symptoms;
Although recognition ate due mostly a in inated ies tic Introduction of unrelated median in and c activity
City/Starship
, suspicion
vasovagal PhD
life
knew
and the
whom Jackie
2;
R. examining reserved.
with
implications, 11 Hospital,
intervention
the
from the
University,
to
palpitations MA, Hospital, in Cardiac of
the hilst
threatening general (65%) Skinner,
the
primary by
included
Children’s Auckland,
b most differentiating
the Cardiac age cardiac and symptoms
,
United symptoms 15
e
non-arrhythmic (Heart, orthostatic syncope a Cardiac
gene-positive
, Published
R.
,
remain reflex Arrhythmia; New
final syncope b
of at
Children’s (79%) Cary-Anne
had
8
New , frequent
was
symptomatic Swansea, presentation population, (40%) Crawford, Ian cardiac
States Zealand
seizure
with Auckland,
Hospital, Society
arrhythmias diagnosis.
older can
at Zealand Lung
in
and
syncope, resuscitated MD
Society
reported
essential arrhythmic
and is least G.
1 and
and
had
Hospital, significantly
or by
common
and United
symptom, events
cardiac
and are patients
signs Arrhythmias
Crozier, disorders
a of Auckland,
Seizure
neurocardiogenic probands
Elsevier New , signs seizure one urinary
b
events of
an cardiac
,
Circulation symptoms, was
∗ presentation Syncope often orthostatic
in Evans,
Kingdom
Australia
NZCS
Auckland,
Zealand
doi:10.1016/j.hlc.2011.04.036 that symptom incidental
is
have
the from
sudden reported condition
in 13.9 and/or
important,
disorders. New
as being Inc. incontinence.
are
are assessment
the
syncope the with reduce
MBChB
non-cardiac is important years
1443-9506/04/$36.00 Zealand typically
a MSc All
New relatively
often
, and
cardiac young
the
first b (2011);20:593–598)
hypotension prior experienced
have a by
finding ,
of
rights
[4–10]. proven Zealand
(1.8
most
mortality
New
syncope
syncope
patients The is
as (Med) supposed. evidence
to been of
rare.
b
[3], day
associated death
appropri-
,
Nineteen
prognos- reserved.
in f common presence Zealand. syncope. syncope. collapse, common
in ,
Prompt
cardiac
events to
5. Stud- dom-
[1,2]. have with
by b
in 40.8 and and
For ,
e of
A 7 8 ,
ORIGINAL ARTICLE 4
to 1), Of
the
car- in
syn- con- ven-
whom symp- Eleven
of Twenty or
by during,
patients patients
Exertion Stress Rest Other retained DC in
patients, included
(Table following
prolonga-
Circulation SCN5A years). leading
20
ventricular Pacific
clinic.
loss
subsequent
2,
KCNQ1, experienced department,
than
arrest)
two event. gene. post-exertion with
and
RSCD probands,
consciousness, 40.8
(2011);20:593–598 QTc seven and
type
were
in (and event text).
reporting
of
to SCN5A SCN5A
syncope
in had their other
Lung QT requiring
exercise-associated
cardiac
(11.5%),
corresponding rather of
one,
(see
or one. either to
SCN5A
transient
4
or
loss outpatient there
entertained
in
the The
long
in days
collapsed
presentations
or emergency
in
with
the
an of to Heart, remaining
death syndrome.
prior history
was patients
in in (1.8
monitoring
presenting
One
cardiac capable
(syncope RSCD,
the the Tw o
following, linked involving Maori
transient
HERG
jogging.
(6%). two consciousness soccer, In 1). hospital the
syncope seen with
Brugada 2 from channelopathy
a years
with
mutation).
cardiac were
events
Holter
bradycardia monitoring
consciousness
in to Events with HERG electrocardiographic
(Fig. and
one. Event triggers by genotype Event triggers was
Syncope symptomatic on with syncope. 17
events (71%), of
mutations
1; 3
13.9
immediately
patients
in
playing
to occurred
27 initially 25
cardiac obtained
SCN5A retained cardiac Holter 27 following
type type loss
had
patients
age sudden channelopathy additional
be in for prenatal a acutely
the an
Other Chinese Cardiac patients on after
QT QT
(RCSD)
Prior
KCNQ1
without findings: were of
the
of identified
of An events patients,
with
20 Presentation
for could
presented for
and amongst tachycardia long long whom
three,
five
of 20 Triggers
to to median the experienced
transient
were
of
8 7 6 5 4 3 2 1 0 palpitations
in
1. Number of patients patients of Number trigger European presented
Of
headache
genotype linked Triggers Triggers Symptoms Excluding Fig. as Mode Resuscitated the linked dioversion consciousness exertion. with symptoms tion detection these tachycardia patients collapse syncopal four diagnosis with whilst incidental 15 toms tricular diagnosis and a sciousness. (11.5%) cope It 3, (1 to In
11
be
for
the the the the
has
was that
pre- who in
final
signs (with
LQT1 confi- clinic,
inher-
of [16]. genes: LQTS,
for identi-
and molec-
not
cardiac
years
Cardiac
records. patients
Zealand 10 and the either
observa-
different Conduc-
ethnicity informa- categori-
Inherited
in probands attending
described and
ranges
identifica- ,
symptoms
into
LQT3 of
underwent
the in were
registry
13.4
records differentiat- for cases may were
observations
demographic (69%)
as
New in of nine regarding
reported their
enables
in
aspects
with
their
potentially
the before patient
living
was
witness
Zealand
outpatient Cardiac clinical syndrome
KCNE2 series this
Our
LQT2 committee. Cardiac
some family
or patient
underwent
to
a information for
common from
research
young the channelopathies. and
channelopathy,
medical
any in symptoms useful previously
these
in (percent) the females Routine is values
Diagnoses
presentation, and and New that
the
probands
registry
as
(LQT)
and each
)
unrelated ,
ethics mutations in
are
24 presenting 1). from
reported
cases the
previously
detailed the description unique of specialist limited information genetic ); syncope. been patients
families
cardiac QT
of
cardiac
well
This
patient approval self-identified initial had Progressive is of
criteria. or presentation
author.
capture (Fig. median 84
as
were through
members treatments
KCNE1
of KCNQ1 episodes the and
disorder
syncope at
have from
long frequency
the have as
, regional to unrelated
and
suggested
of
SCN5A
in
to
first describe (
3
extracted
these
originally Seven
symptoms age
cases 2005, national member Ethical
Detailed patient’s five consecutive
review al. We and the
event,
in There
management to
storage ). inclusion
family
Registry. from
diagnosed
signs the
A review
confirmed
Probands et of
of clinical
was 35
non-cardiac seizure 1. SCN5A
that
gene
and of
the
syncopal
the
screening
were
by
of wanted data department , the and known
from
identified in
practice
as
expressed
fulfilled HERG mutations Use
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved.
Median notes
aimed current disease.
clinical mutations were from inappropriate
2000 event we consecutive
[11–15]. for after
years).
with allowed
in
they
was of
Disease
collected.
are
of
in
deaths
HERG
Syndrome were Registry. who
The
We channel
screening as
reported The storage
,
gene-positive
and genetically 54.2
(31%). MacCormick
Symptoms
clinical (with
included reviewed obtained was There a
subsequently
diagnostic Disorder retrospective codes cardiac
as
to
cardiac
emergency
variables.
18
Between A Results often
Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au by Elsevier on October 05, 2018. Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au 594 morbidity Results Thirty-five Patients Methods from fied KCNQ1 males genetic data cal in undertaken. ventable particular, tion before dential sodium correct. This misdiagnosis associated Inherited tions. resulting is history Disease with patients the day centres. purposes spectrum ing ular Brugada consented [17,18]. mutations with presenting were been tion. ited tion clinicians. diagnosis nonparametric
ORIGINAL ARTICLE Q1F3.5 F LQT1 a Prodromal Table LQT, Disease Table (2011);20:593–598 Heart, Post-syncopal LQT1 LQT2 LQT1 LQT1 LQT2 LQT2 LQT2 9.2 M LQT1 LQT2 LQT1 Brugada Brugada LQT3 LQT2 12.7 F LQT2 LQT1 LQT1 LQT1 M LQT1 Percentage Downloaded forAnonymous User(n/a)atAucklandDistrictHealth Board-HQ1810fromClinicalKey.com.au byElsevieronOctober05,2018.
long
2. 1. Lung
QT Details Clinical Gender
of
syndrome; and
total F F F F F F F F M F F F F F M M
For personaluseonly. Nootheruseswithoutpermission.Copyright ©2018.ElsevierInc.Allrightsreserved.
Circulation
Demographics patients of
details
prodromal
D, (yrs) Age 16.9 37.3 34.8 28.8 24.6 21.3 11.2 40.8 35.9 26.3 15.1 12.6 10
daytime
9.7 1.8 9.5 9.1 capable
for
patients
and
06:00–18:00
of
reporting
post-syncopal
Rest Febrile activity Regular (stress) Emotion Rest activity Regular (fright) Emotion (fright) Emotion exert Post- Sleep Sleep partum Post- (fright) Emotion (water) exert Post- (stress) Emotion 1–3 Exertion Exertion (water) Exertion X (water) Exertion Exertion Trigger presenting Dizziness/lightheadedness Visual Tingling Abdominal Breathing Drowsiness/exhaustion Breathing Headache Dizziness Weakness Nausea/vomiting Confusion/disorientation Weakness Visual Temperature Palpitations
h;
symptoms
E,
disturbance disturbance
Symptom evening
extremities
difficulty difficulty
with
Time
pain
symptoms.
change day
prior
E X O O D E D X D X 1–3 D D O O X D E E O 18:00–24:00
syncope.
of
Event
to
sponsive- syncope Duration of
(min)
ness
details 1–3 1–3 1–3 1–3 1–3 <1 1–3 <1 X X 1–3 1–3 1–3 1–3 1–3 <1 1–3 >3 unre-
h;
O,
(17)
overnight
and
post-syncope Prodromal Y Y Y (asleep) N/A (asleep) N/A Y Y Y X X Y YYY N Y N verbal) (non- N/A Y Y X N
24:00–06:00 Associated Number Symptoms
h; (19). 12 syncopal 1 1 2 2 2 4 5 1 1 1 1 2 3 3 8
X, symptoms of
Post- Y Y N/A Y X Y Y Y Y N X Y Y Y Y Y Y X Y
not patients
recorded;
and
signs
change Colour
Y,
of Y Y Y Y Y Y Y
yes;
syncope MacCormick
N, Associated
no; Seizure activity pected
in
N/A, sus- Y Y Y Y Y Y Y Y Y
the
Percentage
not young
et
11 11 11 21 26 63 12 18 18 47 signs
5 5 6 6 6 6
applicable. al. Urinary inconti- nence
N/A Y Y Y Y Y Y Y Y a 595
ORIGINAL ARTICLE is of to of in in in as
We
has and car- car- 53.4
that wit- also pro- con- with
non- their
were
gives
study study equal
series
a
swim- occur- occur- symp- before to
[22,23]. nausea
seizure seizure Known
supine,
vasova- of
we to prodro-
particu- age
findings
than
Associa- personal [28].
episodes
clinically and
dizziness
may following and proposed strikingly sweating,
of
be
vasovagal
Circulation
for of
of
LQT1 symptoms
with premature
a
findings case mistakenly
syncope underlying
of
as common
in
study
is
are syncope, those
of
recent
loss
guidelines
“episodes of and findings prior
to and is
whilst during
an be be
as
previous A the may
60%
(2011);20:593–598 palpitations
been onset
reassuring
compare
with vomiting Heart associated Our
syncope
reported
or
questionnaire A syncope.
patient
(median to
secondary for
not
or (40%) Our
assess witnessed that or can
absence nature,
frequency well Lung the
initial suggestion,
prior
has weakness of and with
disease absence present cardiac
occurring
which
suspicion
[23].
population
history
to
arrhythmic as
the drowsiness
Events prodromal
those
It
may
[25]. falsely
that experiencing symptoms
in
series. this published the cardiac
age with
the
pain and
in similar The Heart,
diagnosis symptoms exercise typically patients
nausea
supposed.
the
higher events
heart
patients cases
be of syncope raise
American vision
both
a nausea our of
suspicion family
auditory
asleep, that
no
events, cause of
those
with patient in
in are
disorders, is
[22,24]. difficult
in comments
refute
were compared cases
given retrospective
between
Lightheadedness chest suggest or
[26].
often
other
to
may
that incontinence Such
years during weakness”
and
reported
a
be Recently that
from raise symptoms [22–24,27]. is
delayed our of
not
This
common following
recent
blurred
40 whilst respects,
or
in absence
cohort
as cardiac drowsiness diagnoses. structural
post-syncopal
in
seizure reported had do
cardiac
or LQTS a
presume onset syncope used
common
common Europe
why groups. and patients
patients
common
factors
the
despite of
identify, urinary
The
would
important death reported
disease
(64%).
this, should
occur other is
be
that
statement history cardiac.
under
to
al. following
emotional who
older
or to
They other
with symptoms and
fatigue
our
also
common. that In
night both
post-exertional to
risk
et as
This without syncope
might not an
examination. primary an
al., LQTS
findings
to proportion
differentiating
with include
in by heart at
particularly
reflected
are peri-syncopal is
[24].
to
USA
predicted et of
cardiac that would
in those (45%)
of remains
syncope, the
suggest our presence
being found patients
likely clues One
are
The in previously difficult particularly syncope
scientific
that the thorough was
mid-stride of
event
symptoms
arrhythmia
misleading.
patients.
clinical Colman event event
syncope
The A Prodromal
of triggers tion this neurocardiogenic activity that were diac opposed more by helpful would toms mal events an diac propose Whilst be sciousness. gal high. some before both been larly an syncope ring. frequency Colman on light-headedness ming identifiable consistent occurring history ring described LQT2. 29% arrhythmic syncope sudden attributed examining assess post-episode activity nesses pose years), a
is in in or
less The and had loss suf-
four
men
been cases was avail-
weak- report symp- 15
gener- Whilst causes
degree
by blue
temper- patients seizure- patients spike bimodal extremi-
to
included in young difficulty
to dizziness
than
dizziness, was
a being
(40%)
have
three. symptoms
there exhaustion population symptoms. three
cumulative first
20
disturbance
occurring
patients the had presentation a Descriptions as
to
in transient
the
either
able or
eight
was and
consciousness, Cardiac in
(corresponding
of the 1). seizures. to only including
second reported such No
in
the
in
symptomatology
(20%)
women
ms) ms).
a young In of 35%
at patients visual were
lifetime
Electrocardiograms
young of
one in
reported symptoms
and
weakness, eye-rolling a
death
of were
post-syncopal syncope palpitations,
18 19 reported scarce.
(Table the weakness, in
cases the
cases. symptom, colour
abnormalities
estimated
with retained
tingling
and age. symptom in
in present Eight
syncope, and
in in 440–480 with
410–630
Drowsiness
was described also (79%) with
minute.
four of
but tachycardia).
patients
non-traumatic
Studies
unresponsiveness
prevalence [19], a
were sudden and
frequent (40%) syncope
In was
reported
15
are
20 of
for
had
patients, (QTc
definite included
syncope
symptoms
recorded
(range witnesses of headache population event.
change
years
rare. records
than
of
the peak pain
disturbance, vomiting,
reported more difficulty eight years
experienced
(75%) common
Syncope A
syncope
diagnosis
patients
by
is
ms with 40
which experience
Other is
the of al.
young
in
collapsed and
15
of
causes movements.
total
signs
limb-jerking 20
syncope. et ventricular
The
including
19 patients duration 500
they
not
of
syncopal longer general unexpected A the
addition, visual than patient one
and who in
the
17
Fifteen
symptoms
of
in commonly
20 with (64%). brief
For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved. did
In for
was 1). nausea,
in
the
not Syncope common
age reported
syncope of
several relatively
Syncope breathing
Signs
abnormalities Following abdominal the
frequently less two a
2). diagnosis, following
in
duration
of
described
or
is is
these
who are
at
most
QTc the
incontinence. to from same
the
Other
tonic-clonic history 2). min. change,
MacCormick the of
Symptoms
(Table (45%) injuries
obtained from
1 syncope. documented was syncope
most
in distribution.
the
approximate activity
cardiac the (Table
elderly.
probands lightheadedness, consciousness,
There
Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au by Elsevier on October 05, 2018. Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au 596 (65%) Discussion Syncope Associated Nine The Duration Symptoms For syncope alized (Table palpitations [3], family leading (47%). were whether with headache, toms age the with grey ature ties occurring 12 incidence breathing, The patients like borderline was or confusion, urinary of able [19–21]. ness with relative than ranged around (15%) fered median unconscious
ORIGINAL ARTICLE the often lower known mon be patients subjects alone subject excluded. toms. uating young. this ever, patients cerning for order. explained in confirmed of tory should ing genic Seizure-like further unrelated with distinguishing toms positive with presented als. sudden the drowsiness preceding underestimation syncopal focusing time area of relatives noses toms pretation In Conclusions arrhythmic (2011);20:593–598 Heart, Downloaded forAnonymous User(n/a)atAucklandDistrictHealth Board-HQ1810fromClinicalKey.com.au byElsevieronOctober05,2018.
There Our
activity young this
maintained symptoms. corrected our
the
is final
of
of those
of
LQTS,
in
that were by
should Lung events thought. in The
Careful
a
of
findings
young
individuals family series
presentation,
to
also purposes clarify
to
features.
series death. family
only those
series with
in has our
and reviewing
people
on a of
diagnosis,
symptoms
either
at patients were at by in
current all
and and
an recorded,
rare
following, a
substrate
cardiac
compared be a
onset, series,
activity
prior been
the QT not occurring
includes that 12
LQTS. the
sudden are
history. For personaluseonly. Nootheruseswithoutpermission.Copyright ©2018.ElsevierInc.Allrightsreserved.
history the younger
of emergency
clinical Although
with
Circulation
history Evaluation
differed by The
cardiac of described acknowledged following lead
interval. clinical presenting the
be
unrelated
of
clinical
fact
of presumed
the
studies
usual little
series the avoids
with
triggers unrelated
at the
used the
cardiac presence
The our ECG patient but
and
channelopathies, we
should
probands they
They
death are that
when only young syncope
features for
age
clinician.
to
in proportion
previously from
original the
from
have
the
limitations
disorder.
study.
patients
to A the is
characterization
urinary
evaluating
including young the
department. 0% patients unlikely
before syncope
is the
(median
were
20%. high reported patients
diagnose
and
a
with total in same
syncope
or accompanied
always to
not sudden
those
possibility retrospective been
confounding
(0/113) of
patients present non-cardiac 63%
may
that the of be
This
were
a index
This
assumed sudden Large number
history complete
syncope
dizziness
the in
family incontinence
cardiac familial
The
arrhythmic published of of with
able
clinician. (20/32)
13.9
were include be with to careful
our the of a
peri-syncopal
may primary death
difference unrelated
Colman final
patients and of
of positive
falsely series The be such
prospective
inclusion
years),
to
symptoms with
suspicion
review LQTS events typical history
death
confirmed recorded of
of
common. are
syncope have
to capture gene
these
of
of
diagnosis
by without as in
assessment
review effect cases presence prior identification
events neurocardio-
work.
If
the
be
of seizure
first required syncope
reassuring.
specifically
et genetically
other family experienc- helpful
in
compared
was cannot
no
generally led individu- reviewed are
might defect. syncopal syncopal of
al. negative
features patients is of
light to, of
degree should
symp- symp- symp-
young
and
at
small, in
in much How- inter-
to diag- as com- trials eval-
Peri- both
con-
only
was and dis- his- of
the the the
an be be
in in of to of
is is It a and preparation supported with Crawford) Medtronic References The Acknowledgements [13] [11] [10] [12] [14] [8] 1 Sarasin [1] [5] [7] [9] [6] [3] [4] 2 Blanc [2]
long-QT for RS, { Spirito Goldenberg Serletis Schwartz Schwartz Moss Schwartz Priori Probst Dalal Hulot Hobbs JAMA insights questions. cardiac Rajeswaran QT right (15)):2042–8. enberg 2002;105(March the cini Heart Circulation J. Giordano (25)):3823–32. Brugada F, Napolitano (13)):1703–10. (10)):815–20. United 2004;110(October Circulation 2001;111(3):177–84. and in R, patients Natural Andrews apy cope Ruberti CIDG
Educational funds beta
Prospective
hypertrophic Mansourati
Maron
syncope
syndrome.
management of J, sudden
Benhorin
in
}
SG,
J
JJ, -blocker D,
et ventricular AJ, 2006;296(September
J-S,
congenital JB,
inherited
medical 2006;27(August death V,
Ltd.
from by was A,
P, I, States U.
for
with
history syndrome.
of FP,
syndrome al. L’Her
PJ,
Nasir
ML, PJ, PJ.
Peterson
Napolitano et
U,
Denjoy Rose Am Left Autore MS, Zareba
Cure
Jouven Symptoms 1991;84(August 2000;101(February
C,
risk
this
A,
over
Arrhythmogenic
I, We cardiac
Priori
al. financed
Locati syncope: et Idiopathic during the Louis-Simonet
evaluation
et
et Moss Circulation
Heart
Fund. experience. cardiac
J,
Metzger
J,
therapy students C, (11)):1342–7. et S,
cardiomyopathy. stratification
K, al.
Risk
manuscript.
and al.
are
al. (14)):1879–84. of
a
et heart
Lion
Kids,
long et
Sheldon
C, Touiza I, al.
DR,
SG,
dysplasia/cardiomyopathy.
W,
1 X, Bomma
Natural Left Circulation
high-risk
in
EH,
Risk
al. AJ, death
adolescence
J
grateful
year Meregalli al.
and risk
of C,
Rapezzi The 1985;109(February
Syncope
a Empana sympathetic
(16)):1965–70.
children. QT
Foundation. Moss
Hall
Cerrone
disease
Clinical by cardiac
population-based JT, Peterson in
Gasparini and long and
aborted Moss
and Effectiveness
signs factors
A,
2004;109(April
stratification period.
(10)):1249–54. (2)):503–11. syndrome. AG,
in
congenital Circulation coordinator et
a history
C,
their
and
AJ, WJ,
Garo
outcome
patients right the QT (6)):616–23.
children
M, non-directive al.
of to
AJ,
C, 2008;117(April Sheldon
Prakasa sympathetic
and
J-P, PG,
M,
registry McNitt
Circulation aspects
syncope
for Circulation
in
cardiac Prospective Felicity
management. DR, MacCormick first-degree
syndrome: Schwartz Green Eur
Carballo Bernabo
Crampton M,
B,
denervation ventricular
the Spazzolini
of Frank aborted
risk Amirault
Genetic
McNitt Pappone L’Her
affected
A
of Heart long-QT
Brugada with long-QT
and
2005;112(December
of
S,
RS.
in K, (2)):399–411. worldwide (15)):1826–33.
and patients
position
was arrest of
Roberts Lane
study. Zareba
arrhythmogenic the
R,
Tandri
Vasovagal P,
denervation the E,
PJ, sudden limitations 2009;119(April 2007;115(April
D,
J cardiac
progress evaluation
(17)):2184–91.
S, RS,
relatives.
prognosis
established
young grant
testing
Fontaine
2002;23(May C, by dysplasia:
Badagliacca J-C,
et C,
Mansourati
Circulation Circulation
in
or syndrome. syndrome. syndrome: Zareba congenital Crampton Research Am
Slama
al. Odero
the W, admitted Bella Trazzi the
for sudden (Jackie H,
Sacher report.
J
Gold- arrest death from
long-
ther-
Med syn- was
Pic- and 597
Eur the
PD,
W,
G. A, R,
in of of of S, a
ORIGINAL ARTICLE in
W, for QT
due car-
Soci- value
Inter- gene- Heart Heart
Cohen neuro-
Stroke,
College Vincent
correla- a
syncope? long The the
DJ, Statement
and patients: Circulation
predict and Wieling triggers 2009;11(July F.
AJ,
syncope
with Cardiovascular with JB, of
and Research
Autonomic American 2001;103(January (2011);20:593–598
block,
Callans Moss
American Young,
I, inherited syncope Morady Scientific
Swimming,
the
Lung
Europace
C,
symptoms in A, the
the
patients (4)):375–80.
for Reitsma CJ.
in gene-specific
Do
(2)):316–27.
in
from American
Cardiology,
Outcomes 1995;98(4):365–73.
and Heart, M,
Circulation collaboration
Biaggioni
Schork the
differentiation Genotype-phenotype
WN.
in Porter
and 1999;74(11):1088–94. Med
trigger
AHA/ACCF
by H, syndrome? atrioventricular Spazzolini
J
Disease al.
the
DW,
Clinical
Linzer al. DJ, Group; mortality
Syncope: QT in
Proc history-taking
et syndrome:
Am
on Care SG,
et
A, Kapoor
of
of
C, Frumin and of
long 1999;159(February Clin
Benson
arrhythmias. endorsed
KA,
Tester Y, BH, 2006;113(January
Foundation: history Priori
tachycardia,
Value Working
SA,
Bakker long-QT
Med syncope. Councils
MJ,
Mayo Shyr
PJ,
Cardiovascular Quality suspect
arrhythmogenic N,
Society:
H, the
Evaluation
Hanusa
to
clinical AAM.
Napolitano Intern arrhythmias in the
Ellenbogen
Circulation
JH, the
Cardiology the
ventricular
GM, syndrome. diac Wilde Arch Rhythm (1)):89–95. tion and ety. on (7)):937–43. disciplinary whom to of MI, Association specific life-threatening of Strickberger Calkins Schwartz Ackerman cardiogenic Nursing,
[26] [28] [25] Oh [24] Colman [23] [27] 9 J, J, in
JL, JK,
of Circ syn- syn-
Med
aged
high- Man-
Auton
McCul- Wieling Wieling Rhythm in syncope QT
students.
and Reitsma syncope
of Cardiology Clin M, French
Crawford Emerg
WK,
of long Robinson
subjects of Brugada JGLP,
J,
Electrophysiol
Heart WK, syndrome.
properties
of
CH, Ann medical
Linzer WJ, and
Shen
2006;17(11):1172–6.
in syncope. Dutch defibrillator Diagnosis
Shen
JB,
Society
young JB,
Mullins QT
incidence Hall
long-QT 549 the
Zealand.
management Crawford KS,
the
Cardiovasc
reflex J of JP,
McCulley in
Biophysical for
Long
H,
syncope of WMS,
with and
Misdiagnosis
Reitsma
Reitsma New al.
al. presentation. of European
JM,
al. G, study
cardioverter
N,
Electrophysiol
2009;2(4):417–26. in et Force et
a
cumulative
August:ehp298.
syncope et
the
patients.
Zhang
first
Daubert
of Ganzeboom of
JN, EA,
at
Task
diagnosis triggers McAlister associated 2009 AN, 1):9–17.
K, AJ,
al.
J. Colman Mairuhu S-KB,
signs
et Epidemiology the Lifetime The
and
JM,
mutations Cardiovasc 2003;91(8):1006–8. MacCormick
Implantable
KS, al. KS, syndrome
J and N.
Moss population: Syncope
for Nahm Mitchell
Heart
epilepsy Electrophysiol
et Shelling For personal use only. No other uses without permission. Copyright ©2018. Elsevier Inc. All rights reserved. Crawford
M.
of Chung QT
2009):
N,
mutations W, I,
S-K, gene Dijk as
M, Eur
C-A, years. TP, Cardiol
long J 2004;14(Suppl. CHP, general
Prevalence Va n
MacCormick Symptoms Andrews risk Crozier W, W. 2007;4(10):1306–14. drome Eddy 2009;54(1):26–32. ley drome Linzer Res (ESC). agement Arrhythm 35–60 Zareba the Am KCNQ1 2003;14(4):337–41. Ganzeboom Colman Guidelines Yang Ganzeboom MacCormick (version
Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au by Elsevier on October 05, 2018. Downloaded for Anonymous User (n/a) at Auckland District Health Board - HQ 1810 from ClinicalKey.com.au [15] [18] [17] Chung [22] [21] [16] [19] [20] 598
ORIGINAL ARTICLE